University of South Florida team conducts trial for HIV vaccine

Tampa, FL (May 14, 2002) The University of South Florida College of Medicine has begun the human trial for a new experimental HIV vaccine at the Tampa General Hospital Clinical Research Center.

The national study, sponsored by Merck & Co., will assess the vaccine's safety and ability to produce immunity in healthy, uninfected adult volunteers. If successful, the small preliminary study would pave the way for a larger study of the vaccine's effectiveness in people at high risk for HIV infection.

"Of all the potential vaccines studied over the last 20 years, this is one of the most promising to move forward as a candidate for prevention of HIV disease," Jeffrey Nadler, MD, professor of medicine and principal investigator for the HIV vaccine trial in Tampa.

This is the first time that all three components of Merck's HIV vaccine using a prime boost regimen will be tested in humans.

USF/TGH is one of two research centers in Florida and 16 nationwide involved in the placebo-controlled clinical trial. Merck expects to enroll 126 people nationwide in the 18-month clinical trial, including 10 at TGH.

Traditionally, vaccines, such as the polio vaccine, work by encouraging antibodies to prevent infection. However, most vaccines designed to stimulate production of antibodies against HIV have not worked well because the cryptic virus changes itself slightly to evade attack.

Instead of building antibodies, this new HIV vaccine boosts the activity of killer cells in the immune system, called T-lymphocytes, to target and kill the cells containing HIV. "The challenge is to stimulate very specific responses that are directed at the HIV itself" without destroying healthy immune cells, Dr. Nadler said.

Earlier this year, Merck announced that the vaccine sharply slowed the reproduction of the AIDS virus in laboratory monkeys that became infected with HIV. In contrast, most unvaccinated monkeys died or developed AIDS. In addi

Contact: Anne DeLotto Baier
University of South Florida Health

Page: 1 2

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:

(Date:8/15/2019)... ... 2019 , ... Serialization deadlines in the US and European ... aggregation becomes fully applied in the United States in 2023, pharmaceutical companies are ... now, most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system ...
(Date:8/14/2019)... ... 14, 2019 , ... Representatives with MyBioGate announced that China Focus@Biotech Week will ... “We help innovative projects connect with Chinese pharma and investors in healthcare innovation,” said ... to explain that as a part of Biotech Week Boston – the annual biotech ...
(Date:8/6/2019)... ... August 06, 2019 , ... A study released today ... have far-reaching implications for personalized medicine, especially when seeking treatments for children with ... predict which stem cell donors and manipulation methods might yield the best therapies ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... July 11, 2019 , ... At the most recent stem ... to eight military Veterans under the R3 Heroes Program. The Veterans included individuals and ... Heroes Program allow anyone to nominate a military Veteran, teacher or first responder to ...
(Date:7/9/2019)... , ... July 08, 2019 , ... ... The company’s SmartLight Indicator was recognized as the 2019 Innovative Product of the ... forward. The prestigious awards were during Sensors Expo & Conference 2019, ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results ... properties of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , ... differentiation peak, change in crystallite size , Over 142% increase in particle ...
(Date:6/18/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, ... a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical trial ... is the first of several planned clinical trials which will enable qualified PSC-enrolled physicians ...
Breaking Biology Technology:
Cached News: